IMC Chicago
RNAM

IMC Chicago’s Avidity Biosciences RNAM Stock Holding History

IMC Chicago’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,400
Closed -$750K – 5917
2025
Q4 		$750K Sell
10,400
-22,500
-68% -$1.45M ﹤0.01% 3192
2025
Q3 		$1.43M Buy
+32,900
New +$1.33M ﹤0.01% 2469

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

IMC Chicago's RNAM Position: Q1 2026 in Review

IMC Chicago sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 11,016 shares — an estimated $795K sold.

IMC Chicago first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $795K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • IMC Chicago reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 11,016 Avidity Biosciences shares in Q1 2026, an estimated $795K.
  • IMC Chicago first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • IMC Chicago's Avidity Biosciences position peaked at $795K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.